Nuvation Bio Inc Class A (NUVB)
EBITDA Growth
4.61%
Quarterly · Period ending:
NUVB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported4.61%period ending
Latest reported4.61%period ending
NUVB Quarterly EBITDA YoY % (-110.60% → 4.61%)
Year-over-year change
High-resolution chart · PNG
NUVB ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 4.611% | |
| 123.9087% | |
| 40.208% | |
| -33.7886% | |
| 87.3993% | |
| -258.8435% | |
| -257.8284% | |
| -108.8803% | |
| -2,145.0253% | |
| 32.0074% | |
| 33.9681% | |
| 27.8226% | |
| 40.8676% | |
| -1.9909% | |
| 17.1177% | |
| -23.908% | |
| -80.4375% | |
| -3.877% | |
| -82.5995% | |
| -90.1823% | |
| -114.5701% | |
| -122.4228% | |
| -29.4733% | |
| -110.6033% |